Schedule 13D ownership disclosure
Immune Design Corp.
Security class unavailable · CUSIP: 45252L103
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,195,251
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-19-011587
- Form type
- SC 13D
- Filer
- IMMUNE DESIGN CORP.
- CIK
- CIK 1437786
- Filed
- Feb 28, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13D beneficial ownership